Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5989)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2021 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rah B, Banday MA, Bhat GR, Shah OJ, Jeelani H, Kawoosa F, Yousuf T, Afroze D. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World J Gastroenterol 2021; 27(36): 6093-6109 [PMID: 34629822 DOI: 10.3748/wjg.v27.i36.6093] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i36/6093.htm |
| Number | Citing Articles |
| 1 |
Bilal Rah, Rafiq A Rather, Gh Rasool Bhat, Abdul Basit Baba, Ifra Mushtaq, Muzamil Farooq, Tahira Yousuf, Sadaf B Dar, Sabra Parveen, Rukhsana Hassan, Fozia Mohammad, Iqbal Qassim, Abida Bhat, Shazia Ali, Mahrukh Hamid Zargar, Dil Afroze. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.821344
|
| 2 |
Maciej Wiewiora, Janusz Jopek, Elżbieta Świętochowska, Michael Grynkiewicz, Jerzy Piecuch. Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancer. Clinical Hemorheology and Microcirculation 2024; 86(3): 383 doi: 10.3233/CH-231987
|
| 3 |
Michelle F. Jacobs, Elena M. Stoffel. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). Familial Cancer 2024; doi: 10.1007/s10689-024-00372-5
|
| 4 |
Lingxue Tang, Tong Wang, Qianqian Zhang, Sheng Yu, Wen Li, Senbang Yao, Huaidong Cheng, Yuan Seng Wu. Safety and Efficacy of Treatment with/without Ramucirumab in Advanced or Metastatic Cancer: A Meta-Analysis of 11 Global, Double-Blind, Phase 3 Randomized Controlled Trials. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2476469
|
| 5 |
Cincin Zeynep Bulbul, Bulbul Muhammed Volkan, Sahin Soner. Cancer Epigenetics. Epigenetics and Human Health 2023; 11: 275 doi: 10.1007/978-3-031-42365-9_8
|
| 6 |
Abdul Basit Baba, Bilal Rah, Gh. Rasool Bhat, Ifra Mushtaq, Sabra Parveen, Rukhsana Hassan, Mahrukh Hameed Zargar, Dil Afroze. Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.791272
|